GridAI Technologies Corp.

GRDXSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1604191

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenues	—	—	—	—	—
Research and Development Expense	$5.0M	$8.8M	$17.0M	—	$8.7M
Operating Expenses	$15.8M	$12.7M	$59.1M	$26.4M	$14.7M
Operating Income (Loss)	-$15.8M	-$12.7M	-$59.1M	-$26.4M	-$14.7M
Interest Expense	—	$15.9K	$11.2K	$5.8M	$433.9K
Nonoperating Income (Expense)	-$24.2K	-$2.0M	$519.0K	-$6.2M	—
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	—	—	—	-$15.2M
Income Tax Expense (Benefit)	—	—	—	$0.00	$0.00
Net Income (Loss) Attributable to Parent

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$6.9M	$5.4M	$11.8M	$12.9M	$8.9M
Assets, Current	$5.0M	$3.4M	$9.4M	$7.9M	$3.4M
Cash and Cash Equivalents, at Carrying Value	$3.7M	$1.4M	$8.2M	$6.1M	—
Accounts Receivable, after Allowance for Credit Loss, Current	—	$93.0K	$93.0K	$551.5K	$2.6M
Liabilities	$3.3M	$2.7M	$19.6M	$15.6M	$4.3M
Liabilities, Current	$3.1M	$2.5M	$12.3M	$15.5M	$4.3M
Accounts Payable, Current	$554.3K	$720.0K	$2.7M	—

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$12.4M	-$22.3M	-$32.3M	-$11.2M	-$14.0M
Net Cash Provided by (Used in) Investing Activities	-$500.0K	-$500.0K	-$10.3M	$87.3K	-$24.1K
Net Cash Provided by (Used in) Financing Activities	$15.2M	$15.7M	$44.8M	$17.0M	$13.1M
Payments to Acquire Property, Plant, and Equipment	—	—	$69.5K	$4.2K	$24.1K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)